A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/553 (2006.01) A61P 27/14 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2527703
This application relates to the use of staurosporines derivatives for the curative, palliative or prophylactic treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis, or mastocytosis; and to a method of treatment of warm-blooded animals in which a therapeutically effective dose of a compound of a Staurosporine Derivative is administered to a warm-blooded animal suffering from one of the diseases or conditions mentioned above.
L'invention concerne l'utilisation de dérivés de staurosporine pour le traitement curatif, palliatif ou prophylactique de la rhinite allergique, la dermite allergique, l'allergie à un médicament ou à un aliment, l'oedème angioneurotique, l'urticaire, le syndrome de la mort subite du nourrisson, l'aspergillose bronchopulmonaire, la sclérose en plaques, ou la mastocytose ; et une méthode de traitement d'animaux à sang chaud selon laquelle une dose efficace sur le plan thérapeutique d'un composé d'un dérivé de staurosporine est administrée à un animal à sang chaud atteint d'une des maladies ou états précédemment mentionnés.
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
New pharmaceutical uses of staurosporine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New pharmaceutical uses of staurosporine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New pharmaceutical uses of staurosporine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1840073